Christopher Thomas Giordano

Insider Reports History

Entity
Individual
Location
C/O Tenax Therapeutics, Inc., One Copley Parkway, Suite 490, Morrisville, NC
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Thomas Giordano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TENAX THERAPEUTICS, INC. CEO, Director Stock Option (right to buy) 1.25M Dec 10, 2024 Direct

Insider Reports Filed by Christopher Thomas Giordano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TENX TENAX THERAPEUTICS, INC. Dec 10, 2024 1 $0 4 Dec 12, 2024 CEO, Director
TENX TENAX THERAPEUTICS, INC. May 17, 2024 1 $0 4 May 21, 2024 CEO, Director
TENX TENAX THERAPEUTICS, INC. Jun 9, 2022 1 $0 4 Jun 10, 2022 CEO, Director
TENX TENAX THERAPEUTICS, INC. Jul 14, 2021 0 $0 3 Jul 15, 2021 CEO, Director